newsfilter
← Latest News
GlobeNewswire·

Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors

Regulatory and quality expertise strengthens Board as Candel advances toward planned Biologics License Application (BLA) submission and potential commercial readiness NEEDHAM, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE)